Sionna Therapeutics, Inc.
SION · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $765,696 | $461,204 | $1,103,110 |
| - Cash | $50,831 | $40,985 | $82,695 | $37,788 |
| + Debt | $7,751 | $9,237 | $9,497 | $9,749 |
| Enterprise Value | – | $733,948 | $388,006 | $1,075,071 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$100 | -$147 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$20,178 | -$17,921 | -$19,228 | -$17,966 |
| % Margin | – | – | – | – |
| Net Income | -$20,278 | -$18,068 | -$16,482 | -$15,848 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.456 | -0.41 | -0.374 | -0.359 |
| % Growth | -11.2% | -9.7% | -4.1% | – |
| Operating Cash Flow | -$15,230 | -$18,153 | -$16,288 | -$11,781 |
| Capital Expenditures | -$87 | $0 | -$86 | $0 |
| Free Cash Flow | -$15,317 | -$18,153 | -$16,374 | -$11,808 |